![Tumor size change and OS correlate linearly](/sites/default/files/styles/news_recent/public/news/2023-06/press-card-S1609-Othus-small.png?itok=9XKHJQT5)
Jun 2, 2023
Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors
![S1929 results at ASCO](/sites/default/files/styles/news_recent/public/news/2023-06/press-card-S1929-Karim-small.png?itok=AnXnO1L-)
Jun 2, 2023
Results of SWOG S1929 trial show patients with small-cell lung cancer with SLFN11 expression can benefit from PARP inhibitor added to immune checkpoint blockade
![S1714 results at ASCO 2023](/sites/default/files/styles/news_recent/public/news/2023-05/press-card-S1714-ASCO-Trivedi-small.png?itok=lCSVeAaZ)
May 31, 2023
S1714 results at ASCO 2023: Taxane-induced peripheral neuropathy in breast cancer: frequent, clinically significant, and worse with paclitaxel
![S1011: Less is more in bladder cancer surgery](/sites/default/files/styles/news_recent/public/news/2023-06/press-card-S1011-Lerner-2-small.png?itok=Dpwxy-Gw)
May 30, 2023
Extended lymph node removal does not benefit patients with clinically localized muscle-invasive bladder cancer
![2023 ASCO Annual Meeting](/sites/default/files/styles/news_recent/public/news/2023-05/press-release-card-ASCO23_0.png?itok=CqMHB2fJ)
May 30, 2023
SWOG researchers have also contributed to an additional 11 abstracts on studies led by other groups.
![Dr. Primo Lara and Dr. Dawn Hershman](/sites/default/files/styles/news_recent/public/news/2023-05/co-chairs-elect-20230515.jpg?itok=f4a7lrAY)
May 16, 2023
Drs. Dawn Hershman and Primo Lara elected group co-chairs-elect of SWOG Cancer Research Network